Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02478411
Other study ID # CYCLE-ICU-001
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 2015
Est. completion date June 2021

Study information

Verified date August 2019
Source Hospital Son Llatzer
Contact Gemma Rialp, M.D.
Phone 00 34 871202133
Email grialp@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study designed to evaluate the functional and motor effects in critically ill subjects at ICU and hospital discharge with the incorporation of a mobilization program of cycloergometric physiotherapy sessions compared with conventional physiotherapy.


Description:

Cycloergometric treatment is described to improve the functional and motor status of critically ill subjects. However, there are few studies comparing cycloergometric physiotherapy and conventional physiotherapy in intensive care subjects under mechanical ventilation. The most relevant of these studies conducted by Burtin et al showed beneficial effects of cycloergometric treatment. However, the duration of the physiotherapy sessions in this study differed between groups as cycloergometric group received a double daily dose of treatment. It is known that the intensity of physiotherapy also affects the functional and motor status.

For this reason, the investigators designed a randomized controlled study with early cycloergometric or conventional treatment, with the same intensity between groups to analyze objective functional and motor endpoints.


Recruitment information / eligibility

Status Recruiting
Enrollment 68
Est. completion date June 2021
Est. primary completion date December 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Criteria of functional independence before hospital admission (Barthel scale > 70 points).

- Invasive mechanical ventilation < 72 hours.

- Signed informed consent.

Exclusion Criteria:

- Neuromuscular disease (peripheric or central neurologic disorder).

- Presumed fatal evolution in 48 hours.

- Conditions that impede pedaling movement (leg, pelvis or lumbar spinal surgery or traumatism).

- Admission due to cardiac arrest.

- Pregnancy.

- Thrombopenia less than 50.000.

- Severe agitation.

- Hemodynamic instability with noradrenaline requirements greater than 1 mcg/kg/min.

- Fraction of inspired Oxygen (FiO2) requirements greater that 0.55 and respiratory rate greater than 30 bpm.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Cycle ergometer physiotherapy
15 minutes of cyclo ergometer physiotherapy with MOTOmed ® Letto 2 device with passive, motor-assisted and active-resisted exercise of the lower and upper extremity, and 15 minutes of conventional physiotherapy
Conventional physiotherapy
30 minutes of conventional physiotherapy

Locations

Country Name City State
Spain Hospital Son llàtzer Palma de Mallorca Illes Balears

Sponsors (1)

Lead Sponsor Collaborator
Hospital Son Llatzer

Country where clinical trial is conducted

Spain, 

References & Publications (7)

Bourdin G, Barbier J, Burle JF, Durante G, Passant S, Vincent B, Badet M, Bayle F, Richard JC, Guérin C. The feasibility of early physical activity in intensive care unit patients: a prospective observational one-center study. Respir Care. 2010 Apr;55(4): — View Citation

Burtin C, Clerckx B, Robbeets C, Ferdinande P, Langer D, Troosters T, Hermans G, Decramer M, Gosselink R. Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med. 2009 Sep;37(9):2499-505. doi: 10.1097/CCM.0b013e318 — View Citation

De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphaël JC, Outin H, Bastuji-Garin S; Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation. Paresis acquired in the int — View Citation

Needham DM, Truong AD, Fan E. Technology to enhance physical rehabilitation of critically ill patients. Crit Care Med. 2009 Oct;37(10 Suppl):S436-41. doi: 10.1097/CCM.0b013e3181b6fa29. Review. — View Citation

Schweickert WD, Kress JP. Implementing early mobilization interventions in mechanically ventilated patients in the ICU. Chest. 2011 Dec;140(6):1612-1617. doi: 10.1378/chest.10-2829. Review. — View Citation

Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP. Early physical and occupational therapy in mechanically ventilated, critic — View Citation

TEAM Study Investigators, Hodgson C, Bellomo R, Berney S, Bailey M, Buhr H, Denehy L, Harrold M, Higgins A, Presneill J, Saxena M, Skinner E, Young P, Webb S. Early mobilization and recovery in mechanically ventilated patients in the ICU: a bi-national, m — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Changes in Pulse Oximeter Oxygen Saturation (SpO2) between end and initial values after physiotherapy sessions ICU admission, with an expected average of 2 weeks
Other Change in respiratory rate between end and initial values after physiotherapy sessions Respiratory rate ICU admission, with an expected average of 2 weeks
Other Change in heart rate between end and initial values after physiotherapy sessions ICU admission, with an expected average of 2 weeks
Other Change in mean blood pressure between end and initial values after physiotherapy sessions ICU admission, with an expected average of 2 weeks
Primary Walking test distance at six minutes At hospital discharge, with an expected average of 4 weeks after hospital admission
Primary Short Form-36 Health Survey (SF-36), physical functioning section At 28 days after hospital discharge, that is an expected average of 8 weeks
Primary Basic activities of daily living score (BADL) At 28 days after hospital discharge, that is an expected average of 8 weeks
Secondary Lung Functional Testing At the end of hospital stay, with an expected average of 5 weeks
Secondary Presence of intensive care acquired paresis (Medical Research Council score < 48 points) During ICU admission and ICU discharge, with an expected average of 2 weeks
Secondary ICU mobilization scale During hospital stay, as expected average of 4 weeks, and at 28 days and at 6 months after discharge
Secondary Isometric quadriceps force (N/kg) Quadriceps strength will be measured with a handheld dynamometer with patients in supine position and 30ยบ of knee flexion. During ICU admission, with an expected average of 2 weeks
Secondary Walking test distance at six minutes At 28 days and at 6 months after hospital discharge, that is up to 1 year
Secondary Short Form-36 Health Survey (SF-36), physical functioning section At 7 days and at 6 months after hospital discharge, that is up to 1 year
Secondary Basic activities of daily living score (BADL) At 7 days and at 6 months after hospital discharge, that is up to 1 year
See also
  Status Clinical Trial Phase
Completed NCT00997269 - Benefit of CoQ-10 in Patients on Statins N/A
Completed NCT00473161 - Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy Phase 1/Phase 2
Terminated NCT01895647 - Effect of Different Electric Muscle Stimulation in Patients With Severe Sepsis and Respiratory Failure N/A
Completed NCT02757131 - Dedicated Ambulator-assisted Physical Activity to Improve Hospital Outcome Measures in Elderly Patients N/A
Recruiting NCT01911312 - Evaluation of Thermal-Aided Muscle Stimulation N/A
Completed NCT02010398 - Effects of the Cross-Training in Patients With Multiple Sclerosis N/A
Completed NCT01154517 - Utility of the History and Physical Exam in the Emergency Department N/A
Completed NCT04393909 - Improving Safety of Diagnosis and Therapy in the Inpatient Setting N/A
Terminated NCT02332187 - Effect of All-Stim 2 Quadriceps Treatments on Limb Muscle Strength In Mechanically Ventilated Patients N/A
Terminated NCT02247895 - Treatment of Muscle Weakness in Critically Ill Patients N/A
Active, not recruiting NCT01032993 - Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms Phase 2/Phase 3
Withdrawn NCT00583206 - Muscle Atrophy in Sepsis N/A
Completed NCT01881477 - Effect of Therapeutic Modalities on the Physical Fitness and Functional Capacity in Critical Patient N/A
Completed NCT00797407 - Effectiveness of Creatine in Preventing Muscle Aching From Cholesterol-Lowering Statin Drugs N/A
Recruiting NCT00666744 - A Randomised Controlled Trial of Family Mediated Exercises (FAME) Following Stroke Phase 3